Inflammatory bowel disease

Endoscopy

Volumn 34, Issue 1, 2002, Pages 63-68

  Marteau, P ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AZATHIOPRINE; CIPROFLOXACIN; FUNGUS ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; PROBIOTIC AGENT; PURINE DERIVATIVE; RECOMBINANT INTERLEUKIN 10; RIFABUTIN; SACCHAROMYCES CEREVISIAE ANTIBODY; TIOGUANINE; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG; VSL NUMBER 3;

APPENDECTOMY; CLINICAL TRIAL; COLORECTAL CANCER; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG METABOLISM; DYSPLASIA; ENTERITIS; ERYTHROCYTE; GENE; GENETIC ANALYSIS; HEALTH CARE COST; HUMAN; ILEOANAL ANASTOMOSIS; INFECTION; INTESTINE CANCER; INTESTINE ENDOSCOPY; INTESTINE OBSTRUCTION; LEUKOCYTE; LONG TERM CARE; META ANALYSIS; NOD2 GENE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROCTOCOLECTOMY; REVIEW; RISK FACTOR; SACCHAROMYCES CEREVISIAE; SCINTIGRAPHY; SERODIAGNOSIS; SMOKING CESSATION; ULCERATIVE COLITIS;

ANASTOMOSIS, SURGICAL; CARRIER PROTEINS; CHILD; COLON; COLORECTAL NEOPLASMS; CROHN DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LAPAROSCOPY; MEASLES; NOD2 SIGNALING ADAPTOR PROTEIN; PROTEINS; RECTUM; RISK FACTORS; SMOKING CESSATION;

EID: 0036159882     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-19392     Document Type: Review

References (51)

1. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
3. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations
4. Inflammatory bowel disease in spouses and their offspring
5. Early measles virus infection is associated with the development of inflammatory bowel disease
6. Measles vaccination and inflammatory bowel disease: A national British Cohort Study
7. Identification of a novel bacterial sequence associated with Crohn's disease
8. Genetically related Escherichia coli strains associated with Crohn's disease
9. Appendectomy and protection against ulcerative colitis
10. Laparoscopic appendectomy in patients with refractory ulcerative colitis
11. The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study
12. Pseudotumorous chronic pancreatitis associated with inflammatory bowel disease
13. Ulcerative duodenitis accompanying ulcerative colitis
14. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
15. Comparative study of ASCA (anti-Saccharomyces cerevisiase antibody) assays in inflammatory bowel disease
16. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease
17. Small-bowel disease: Comparison of MR enteroclysis images with conventional enteroclysis and surgical findings
18. Preoperative MR imaging of anal fistulas: Does it really help the surgeon?
19. The prognostic value, in active ulcerative colitis, of an increased intensity of colonic perivisceral fat signal on magnetic resonance imaging with ferumoxsil
20. 1H magnetic resonance spectroscopy in inflammatory bowel diseases: Distinguishing ulcerative colitis from Crohn's disease
21. Early vascular changes in Crohn's disease: An Endoscopic fluorescence study
22. Long-term outcome of non-surgical strictureplasty using metallic stents for intestinal strictures in Crohn's disease
23. Multiple strictures in jejunal Crohn's disease: Push enteroscopy dilation
24. Intraoperative enteroscopy detects more lesions but is not predictive of postoperative recurrence in Crohn's disease
25. Topical formalin therapy by means of an endoscopic applicator for control of ileoanal pouch ulcer bleeding
26. 99mTc leukocyte scintigraphy and SBFT studies useful in children suspected of having inflammatory bowel disease?
27. Technetium-99m HMPAO-labeled leukocyte imaging compared with endoscopy, ultrasonography, and contrast radiology in children with inflammatory bowel disease
28. The risk of colorectal cancer in ulcerative colitis: A meta-analysis
29. Cancer risk in patients with inflammatory bowel disease: A population-based study
30. Family history as a risk factor for colorectal cancer in inflammatory bowel disease
31. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: A population-based cohort study
32. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis
33. How gastroenterologists screen for colonic cancer in ulcerative colitis: An analysis of performance
34. Surveying surveillance: Are gastroenterologists consistently inconsistent, inconsistently consistent, or poorly educated?
35. Screening and surveillance colonoscopy in chronic Crohn's colitis
36. Smoking cessation and the course of Crohn's disease: An intervention study
37. Attitudes toward smoking and smoking behaviors of patients with Crohn's disease
38. Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: The first 100 patients
39. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease
40. Idiosyncratic adverse reactions to 6-mercaptopurine and azathioprine can be averted by switching to thioguanine (6-TG) in patients with IBD
41. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
42. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease
43. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
44. Probiotics in inflammatory bowel disease
45. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
46. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
47. Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease
48. Advantages of laparoscopic resection for ileocolic Crohn's disease
49. Strictureplasty for Crohn's disease: Meta-analysis
50. Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease
51. Ileal pouch-anal anastomosis in patients with indeterminate colitis: Long-term results